14.22 (-%)
As of Oct 31, 2024
Source:
Intellia Therapeutics, Inc. is a leading clinical-stage gene editing company, focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | ( 857 ) 285-6200 |
Industry | manufacturing |
CEO | John M. Leonard |
Website | www.intelliatx.com |